MarketPulse

tender offer

7 articles
BenzingaBenzinga··Iveco Group N.V.

Iveco Clears Final Hurdles for Leonardo Defence Sale, Paving Way for Tata Takeover

Iveco confirms all closing conditions met for Leonardo defence business sale, clearing final hurdle for Tata Motors' $3.8B acquisition to proceed.
IVCGFM&Atender offer
BenzingaBenzinga··Globe Newswire

Lisata Therapeutics to Be Acquired by Kuva Labs for $5 Per Share Plus Contingent Payments

Lisata Therapeutics agreed to be acquired by Kuva Labs for $5.00 per share plus up to $1.00 contingent payment, closing expected in Q2 2026.
LSTAacquisitionFDA approval
GlobeNewswire Inc.GlobeNewswire Inc.··Na

Lisata Therapeutics to Be Acquired by Kuva Labs for $5 Per Share Plus Milestone Payment

Lisata Therapeutics agrees to be acquired by Kuva Labs for $5 per share plus up to $1 contingent payment tied to FDA approval, with close expected in Q2 2026.
LSTAacquisitionFDA approval
BenzingaBenzinga··Globe Newswire

Servier Acquires Day One Biopharmaceuticals for $2.5B to Bolster Rare Oncology Pipeline

Servier acquires Day One Biopharmaceuticals for $2.5B in cash, expanding rare pediatric oncology portfolio with closing expected Q2 2026.
DAWNacquisitionbiopharmaceutical
BenzingaBenzinga··Globe Newswire

Occidental Petroleum Launches Debt Buyback Program Ahead of March Deadline

Occidental Petroleum announced cash tender offers for senior notes and debentures, with early tender deadline March 4, 2026, and settlement March 9, 2026.
OXYOXY.WSsenior notesdebt refinancing
BenzingaBenzinga··Globe Newswire

Japanese Fund Challenges Yutaka Giken Share Consolidation Over Valuation Concerns

GAM Multistock files injunction petition against Yutaka Giken's share consolidation, citing undervaluation and minority shareholder protection concerns amid Honda Motor's controlling stake.
HMCfair valuecorporate governance
GlobeNewswire Inc.GlobeNewswire Inc.··Monteverde & Associates Pc

Law Firm Urges Shareholders to Review Four Pending M&A Transactions Ahead of 2026 Votes

Law firm investigates four M&A deals for RAPT Therapeutics, Amicus Therapeutics, Tamboran Resources, and Contango Ore ahead of March 2026 shareholder votes.
RAPTCTGOTBNFOLDacquisitionclass action